|Abbott Laboratories, of Abbott Park, Ill.||Advisedx SARS-CoV-2 IgM||Lab-based serology test for use on the Architect and Alinity platforms||Detects Immunoglobulin M (IgM) antibodies to SARS-CoV-2||Received emergency use authorization from the U.S. FDA|
|Cartiheal Ltd., of Kfar Saba, Israel||Agili-C||Cell-free, off-the-shelf implant||For the treatment of cartilage lesions in arthritic and non-arthritic joints||U.S. FDA granted breakthrough device designation|
|GE Healthcare, of Chicago||Vivid Ultra Edition||Artificial Intelligence-based ultrasound system||For use in cardiovascular diagnostic exams||Received 510(k) clearance from the U.S. FDA|
|Varian Medical Systems Inc., of Palo Alto, Calif.||Flash therapy||Experimental treatment modality delivering radiation therapy at ultra-high dose rates||Noninvasive treatment option for patients with cancer||Received an investigational device exemption from the U.S. FDA to initiate the FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01)|
For more information about individual companies and/or products, see Cortellis.